HEXAOM (ALHEX.PA) Fundamental Analysis & Valuation

EPA:ALHEX • FR0004159473

33 EUR
+1.1 (+3.45%)
Last: Mar 4, 2026, 07:00 PM

This ALHEX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall ALHEX gets a fundamental rating of 3 out of 10. We evaluated ALHEX against 30 industry peers in the Household Durables industry. ALHEX has a bad profitability rating. Also its financial health evaluation is rather negative. ALHEX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. ALHEX.PA Profitability Analysis

1.1 Basic Checks

  • ALHEX had positive earnings in the past year.
  • In the past year ALHEX has reported a negative cash flow from operations.
  • Of the past 5 years ALHEX 4 years were profitable.
  • Each year in the past 5 years ALHEX had a positive operating cash flow.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • ALHEX's Return On Assets of 1.46% is in line compared to the rest of the industry. ALHEX outperforms 46.67% of its industry peers.
  • ALHEX has a Return On Equity (3.94%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.70%, ALHEX perfoms like the industry average, outperforming 43.33% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ALHEX is in line with the industry average of 10.33%.
  • The 3 year average ROIC (8.77%) for ALHEX is well above the current ROIC(3.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROIC 3.7%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • ALHEX has a worse Profit Margin (1.46%) than 60.00% of its industry peers.
  • ALHEX's Profit Margin has declined in the last couple of years.
  • ALHEX's Operating Margin of 2.30% is on the low side compared to the rest of the industry. ALHEX is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of ALHEX has declined.
  • ALHEX's Gross Margin of 21.14% is on the low side compared to the rest of the industry. ALHEX is outperformed by 76.67% of its industry peers.
  • In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.
Industry RankSector Rank
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. ALHEX.PA Health Analysis

2.1 Basic Checks

  • ALHEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ALHEX remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for ALHEX has been reduced compared to a year ago.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ALHEX has an Altman-Z score of 2.12. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.12, ALHEX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • ALHEX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.40, ALHEX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.52
WACC7.07%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ALHEX has a Current Ratio of 1.31. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.31, ALHEX is not doing good in the industry: 63.33% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.99 indicates that ALHEX may have some problems paying its short term obligations.
  • ALHEX has a Quick ratio (0.99) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.99
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. ALHEX.PA Growth Analysis

3.1 Past

  • The earnings per share for ALHEX have decreased strongly by -68.84% in the last year.
  • Measured over the past years, ALHEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.22% on average per year.
  • ALHEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.53%.
  • The Revenue has been decreasing by -9.93% on average over the past years.
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%

3.2 Future

  • Based on estimates for the next years, ALHEX will show a very strong growth in Earnings Per Share. The EPS will grow by 37.93% on average per year.
  • The Revenue is expected to grow by 3.02% on average over the next years.
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. ALHEX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.19, the valuation of ALHEX can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as ALHEX.
  • ALHEX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 8.22, which indicates a very decent valuation of ALHEX.
  • ALHEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALHEX is cheaper than 73.33% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, ALHEX is valued rather cheaply.
Industry RankSector Rank
PE 25.19
Fwd PE 8.22
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.11
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALHEX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as ALHEX's earnings are expected to grow with 37.93% in the coming years.
PEG (NY)10.33
PEG (5Y)N/A
EPS Next 2Y37.93%
EPS Next 3YN/A

2

5. ALHEX.PA Dividend Analysis

5.1 Amount

  • ALHEX has a Yearly Dividend Yield of 1.39%.
  • ALHEX's Dividend Yield is comparable with the industry average which is at 2.52.
  • Compared to the average S&P500 Dividend Yield of 1.82, ALHEX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.39%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y37.93%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

ALHEX.PA Fundamentals: All Metrics, Ratios and Statistics

HEXAOM

EPA:ALHEX (3/4/2026, 7:00:00 PM)

33

+1.1 (+3.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-10
Earnings (Next)N/A
Inst Owners15.33%
Inst Owner ChangeN/A
Ins Owners2.84%
Ins Owner ChangeN/A
Market Cap229.02M
Revenue(TTM)617.81M
Net Income(TTM)9.04M
Analysts86.67
Price Target46.41 (40.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.39%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.19
Fwd PE 8.22
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 2.26
EV/EBITDA 6.11
EPS(TTM)1.31
EY3.97%
EPS(NY)4.02
Fwd EY12.17%
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS89.02
BVpS33.03
TBVpS14.6
PEG (NY)10.33
PEG (5Y)N/A
Graham Number31.2
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.94%
ROCE 4.7%
ROIC 3.7%
ROICexc 6.23%
ROICexgc 17.99%
OM 2.3%
PM (TTM) 1.46%
GM 21.14%
FCFM N/A
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexgc growth 3Y-17.24%
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score4
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 2.97
Cap/Depr 27.37%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.99
Altman-Z 2.12
F-Score4
WACC7.07%
ROIC/WACC0.52
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.84%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-48.59%
EPS Next Y2.44%
EPS Next 2Y37.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.53%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-26.54%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-50.48%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136.13%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-114.31%
OCF growth 3Y-21.91%
OCF growth 5YN/A

HEXAOM / ALHEX.PA FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALHEX.PA.


What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.


How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 25.19 and the Price/Book (PB) ratio is 1.


Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 3 / 10.